United to change the trajectory of lung cancer

At Johnson & Johnson, we collaborate across our Pharmaceutical and MedTech teams and with strategic partners to unleash the full potential of lung cancer science to help change the trajectory of this complex disease.

127200133-01 LCAM_v3_1103.mp4

Doctors viewing xrays of human chest in hospital

WATCH: More on our commitment

Innovation

November 30, 2021

“Our goal is to prevent lung cancer from happening in the first place”

Artificial intelligence-enabled mobile screening units. Nasal swab genomic tests. Diagnostics that pair the right treatment with the right patient. For Healthy Lung Month, Johnson & Johnson researchers share the progress that’s being made to thwart the #1 cancer killer.